Symbiomics
PrivateLast Round
Grant
Oct 23, 2025
Total Funding Raised
$2.84M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Symbiomics is a biotechnology company that develops high-performance biological products for agriculture to enhance crop productivity and sustainability.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symbiomics Comparables
Compare Symbiomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nunatak Biotech | 84% | |
| Puna Bio | 79% | |
| Gênica Inovação Biotecnológica | 77% |
Symbiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 23, 2025 | ||||
| Series A | Jun 25, 2025 | ||||
| Seed | Dec 14, 2023 | ||||
| Seed | Jan 27, 2023 | ||||
| Pre Seed | Feb 1, 2022 |
Key People
Founding team and executive leadership
Symbiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baraúna Investimentos | Seed |
| MOV Investimentos | Seed, Series A |
| Arar Capital | Seed, Series A |
| Vesper | Seed, Pre Seed |
| Ecoa Capital | Seed |
| The Yield Lab Latam | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 21, 4.5x the trailing average.
- Jul 13, 2026
Open roles increased to 10, representing 32% of headcount.
Recent news
Latest coverage and updates
- is_developingSep 23, 2026
Symbiomics is developing new generation of solutions for disease management in Brazil on Sep 23rd '26.
- partners_withSep 23, 2026
Symbiomics partnered with Valeouro Biotec on Sep 23rd '26.
Symbiomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Symbiomics's valuation, stock price, and market status.
Is Symbiomics a public or private company?
Symbiomics is a private company.
What is the current stock price of Symbiomics?
Symbiomics is a private company with no public stock price. No recent secondary market data is available.
How much is Symbiomics worth (valuation)?
Valuation information for Symbiomics is not publicly available.
Can I buy Symbiomics stock?
Symbiomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Symbiomics's last funding round?
Symbiomics's most recent funding round was Series A on June 25, 2025.
Who are the main investors in Symbiomics?
Key investors in Symbiomics include Baraúna Investimentos, MOV Investimentos, Arar Capital, Vesper, Ecoa Capital.
Will Symbiomics IPO soon?
No public IPO plans have been announced for Symbiomics.
How can I track Symbiomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Symbiomics's secondary market activity and sign up for updates.